Caliper Life Sciences Launches LabChip XT for Next Generation Sequencing Applications

Automated microfluidic solution for accurate and reproducible fractionation of nucleic acid fragments Hopkinton, Mass. -- Caliper Life Sciences, Inc. (NASDAQ: CALP), a leading provider of tools and services for drug discovery and life sciences research, today introduced the LabChip XT, an automated nucleic acid fractionation instrument. The solution removes a key bottleneck in the current [...]

Caliper Life Sciences Forms Scientific Advisory Board For Next Generation Sequencing

Experts from leading genome centers guide Caliper’s development efforts for next generation sequencing workflow solutions Hopkinton, Mass. -- Caliper Life Sciences, Inc. (NASDAQ: CALP), a leading provider of tools and services for drug discovery and life sciences research, today announced the formation of a scientific advisory board to guide its efforts in automated sample preparation [...]

Thermo Fisher Scientific Launches New Research – Grade Fluorescence Spectrometer

Leading in Sensitivity and Resolution SAN FRANCISCO -- Thermo Fisher Scientific Inc., the world leader in serving science, today launched the Thermo Scientific Lumina, a new research-grade dual-monochromator scanning fluorescence spectrometer that offers a new level of clarity in fluorescence measurement. Designed for both demanding research applications and routine laboratory analysis, the Lumina delivers 0.5 [...]

Ehrfeld Mikrotechnik BTS and Lonza Cooperate in the Microreactor Technology

Ehrfeld Mikrotechnik BTS, a Bayer Technology Services company, to exclusively manufacture and market Lonza microreactors / Joint forces to develop green chemical syntheses Wendelsheim, Leverkusen (Germany), Basel (Switzerland), February 19, 2010 – Ehrfeld Mikrotechnik BTS (EMB), a Bayer Technology Services company, and Lonza signed a worldwide manufacturing and distribution license agreement together with a cooperation [...]

CDEX Inc. Announces Financial Restructuring Plan

CDEX closes first phase of financial restructuring; Carmen J. Conicelli appointed Board Chairman; CEO Search Continues. Tucson, Arizona -- CDEX Inc. (OTCBB: CEXI) (www.cdexinc.com) announces that it has closed the first phase of a financial restructuring plan which provides funds to drive expanded marketing and sales, conversion of existing debt into a two year Note [...]

RainDance and Life Technologies Co-Market Microdroplet PCR-Based Enrichment

Targeted Resequencing on the SOLiD System LEXINGTON, Mass.--RainDance Technologies, Inc., a leading provider of innovative microdroplet-based solutions for human health and disease research, and Applied Biosystems, part of Life Technologies Corporation (NASDAQ: LIFE), announced today they have entered into a strategic agreement to co-market the first solution that combines microdroplet PCR-based sequence enrichment with next-generation [...]

Cellectis and Genoway Close Their Disagreement

PARIS--Cellectis (Paris:ALCLS) and Genoway indicate that the sublicense agreement dated September 7, 2001, relating to the patents and patent applications belonging to the pool WO90/11354 has been terminated as of December 30, 2008. Cellectis and Genoway have agreed on the consequences of such termination of the sublicense agreement, allowing Genoway to deliver the orders placed [...]

NEW Large Particle Flow Cytometer from Union Biometrica, Inc.

Union Biometrica, Inc., the pioneer in the design, manufacture and distribution of COPAS™ Large Particle Flow Cytometers have now introduced their NEW BioSorter®. The well established COPAS™ product line consists of 4 instruments, each dedicated to a specific size range. In response to customer requests, Union Biometrica introduced the NEW BioSorter platform designed for shared [...]

New Animal Origin Free Enzymes from Worthington Biochemical

Worthington Biochemical produces hundreds of different enzymes including several key Animal Origin Free (AOF) products. These new Animal Origin Free Enzymes include AOF Collagenase, recombinant DNase I, RNase T1 and proteases including Neutral Protease (dispase). Using AOF Enzymes avoids potential BSE/TSE and mammalian viral risks and regulatory issues associated with bovine and other animal sources. [...]

Morpho Detection’s Advanced Technology CTX/XRD Explosives Detection “System of Systems” Selected by IAA

IAA Contract Calls for Most Advanced Explosives Detection System to Be Used for Airline Passenger Checked Bag Screening in Israel NEWARK, Calif.--Morpho Detection, Inc., part of the Safran group’s security business, today announced a contract worth up to $50 million to supply the Israel Airports Authority (IAA) with its “System of Systems,” the most advanced [...]

Access IBO on Knowledge Center